Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment

Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment

<p>Secondary Antibody Information</p>

Enregistré dans:

Détails bibliographiques
Auteur principal:	Jonathan M.J. Derry (16648337) (author)
Autres auteurs:	Connor Burns (16648340) (author), Jason P. Frazier (16648343) (author), Emily Beirne (16648346) (author), Marc Grenley (16648349) (author), Christopher C. DuFort (16648352) (author), Emily Killingbeck (16648355) (author), Michael Leon (16648358) (author), Claire Williams (16648361) (author), Mark Gregory (16648364) (author), Jeffrey Houlton (16648367) (author), Daniel Clayburgh (16648370) (author), Paul Swiecicki (16648373) (author), Dennis Huszar (16648376) (author), Allison Berger (15134507) (author), Richard A. Klinghoffer (16648379) (author)
Publié:	2025
Sujets:	Cancer Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Immuno-oncology Methods and Technology Drug Discovery Technologies Novel assay technology Gene Regulation Posttranscriptional and translational control Head, Neck & Oral Cancers Immunology Immunomodulation Innate immunity Tumor-associated macrophages Translational Research Tumor Microenvironment Immune cells and the microenvironment
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
par: Jonathan M.J. Derry (16648337)
Publié: (2025)

Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
par: Jonathan M.J. Derry (16648337)
Publié: (2025)

Supplementary Table S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
par: Jonathan M.J. Derry (16648337)
Publié: (2025)

Supplementary Table S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
par: Jonathan M.J. Derry (16648337)
Publié: (2025)

Supplementary Table S6A from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
par: Jonathan M.J. Derry (16648337)
Publié: (2025)

Supplementary Table S6B from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
par: Jonathan M.J. Derry (16648337)
Publié: (2025)

Suppl video 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
par: Andrew O. Yam (15293045)
Publié: (2025)

Suppl video 2 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
par: Andrew O. Yam (15293045)
Publié: (2025)

Suppl video 3 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
par: Andrew O. Yam (15293045)
Publié: (2025)

Suppl video 4 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
par: Andrew O. Yam (15293045)
Publié: (2025)

Supplementary Table 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
par: Andrew O. Yam (15293045)
Publié: (2025)

Table S9 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
par: Zhihang Chen (17315678)
Publié: (2025)

Supplementary Table S1 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
par: Erika Y. Faraoni (14844897)
Publié: (2025)

Supplementary Table S3 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
par: Erika Y. Faraoni (14844897)
Publié: (2025)

Supplementary Table S4 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
par: Erika Y. Faraoni (14844897)
Publié: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
par: Yu Chen (1234761)
Publié: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
par: Yu Chen (1234761)
Publié: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
par: Yu Chen (1234761)
Publié: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
par: Yu Chen (1234761)
Publié: (2025)

Supplemental Tables 1-8 from Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated <i>SPP1</i><sup>+</sup> Macrophages and Fibroblasts
par: Anuja Sathe (15028097)
Publié: (2025)

Supplementary video from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
par: Min Wu (14962986)
Publié: (2025)

Table S1 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
par: Min Wu (14962986)
Publié: (2025)

Table S2 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
par: Min Wu (14962986)
Publié: (2025)

Table S3 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
par: Min Wu (14962986)
Publié: (2025)

Figure 1 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
par: Ernesto Gargiulo (15134961)
Publié: (2025)

Figure 2 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
par: Ernesto Gargiulo (15134961)
Publié: (2025)

Figure 3 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
par: Ernesto Gargiulo (15134961)
Publié: (2025)

Figure 4 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
par: Ernesto Gargiulo (15134961)
Publié: (2025)

Figure 5 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
par: Ernesto Gargiulo (15134961)
Publié: (2025)

Figure 6 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
par: Ernesto Gargiulo (15134961)
Publié: (2025)

Figure 7 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
par: Ernesto Gargiulo (15134961)
Publié: (2025)

Supplementary Table S1 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
par: Ernesto Gargiulo (15134961)
Publié: (2025)

Supplementary Table S2 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
par: Ernesto Gargiulo (15134961)
Publié: (2025)

Supplementary Table S3 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
par: Ernesto Gargiulo (15134961)
Publié: (2025)

Supplementary Table S4 from Extracellular Vesicle Secretion by Leukemia Cells <i>In Vivo</i> Promotes CLL Progression by Hampering Antitumor T-cell Responses
par: Ernesto Gargiulo (15134961)
Publié: (2025)

Table S1 from Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
par: Hanyun Zhang (15386757)
Publié: (2025)

Table S2 from Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
par: Hanyun Zhang (15386757)
Publié: (2025)

Supplementary Data from Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer
par: Kankan Cao (16437263)
Publié: (2025)

Supplementary Figures SF1-SF9 from Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment
par: Robin M. Hallett (15037427)
Publié: (2025)

Supplementary Tables ST1-ST6 from Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment
par: Robin M. Hallett (15037427)
Publié: (2025)

Cannot write session to /tmp/vufind_sessions/sess_76rvr6hjjq4r46suoj3btrtl41